The reasons for physicians’ discomfort with conversations about dying are as much cultural, social, and systemic as they are personal.
All articles by Tara Haelle, MS
The potential consequences of providing cosmetic treatment to a patient with BDD can extend beyond ethical concerns.
Abilify MyCite adds a digital sensor to the medication aripiprazole. The sensor, an ingestible event marker, is activated by contact with stomach acids and transmits a signal to a skin patch the patient wears, which then transmits to an app.
While researchers continue learning about specific interactions between poor sleep and psychotic symptoms, clinicians should be incorporating more comprehensive questions about sleep into their assessment of patients.
Parents using intervention strategies in addition to the interventionist working directly with the child can be very beneficial, as an interventionist only gets to see a child for a few hours a week.
One of the requirements for diagnosing OCD is that the individuals don’t want to engage in their behaviors. However, youth with autism who have verbal skills often say that they feel content with their repetitive behaviors and have no interest in stopping them.
The prevalence of bipolar postpartum depression is greater than previously understood and requires distinct treatment.
As pharmacologic options have largely remained the same during the last decade, there exists a need to consider adjunctive therapies for bipolar disorder treatment.
Using mindfulness instead of exposure therapy may reach more veterans averse to discussing trauma.
Depersonalizing may help a lot of struggling parents understand the severity of an eating disorder.
In the past, clinicians believed anorexia arose from control battles with parents and that the individual had to develop insight and motivation to recover.
Understanding more about the original protocols of RCTs for various drugs may offer helpful insights into the clinical implications of those trials’ findings.
Clinicians prescribing antidepressants may need to consider augmenting their therapy with another agent.
Transcranial direct current stimulation treats depression more effectively than placebo, but did not outperform escitalopram.
Clinicians should be better trained about the importance and roles of depression screening to improve patient care.
The risk for rehospitalization was 22% lower during treatment with long-acting injectable antipsychotic medications compared with treatment with equivalent oral formulations in the total cohort.
Starting benzodiazepines simultaneously with antidepressants does not seem to influence antidepressant adherence.
Ketamine does not appear to offer any benefits to patients who receive electroconvulsive therapy.
Both postpartum and prenatal depression are among the most significant contributors to maternal morbidity and mortality.
Little progress has been made in identifying effective agents for patients who don’t respond to existing ADHD medications.
The suicide of a spouse can lead to an increased risk for mental disorders and certain medical conditions.
Family-based crisis intervention for suicidal teenagers led to higher levels of satisfaction and greater feelings of family empowerment.
Pre-screening military personnel after deployment did not affect the presence of mental illness.
Patients discharged with a mood stabilizer and an atypical antipsychotic had the lowest rehospitalization rate.
Few adolescents receive methadone or buprenorphine for opioid addiction.
A trial at 3 mental health centers in The Netherlands revealed that patients with financial incentives have better compliance.
Cariprazine treatment led to greater improvement in the negative symptoms of schizophrenia than risperidone.
Clinicians need to be aware of the potential risks when they prescribe antidepressants and other drugs used in the treatment of depression.
Latest News Your top articles for Thursday
Haymarket Medical NetworkTop Picks